Latest Updates
-
Diwali 2026: Chakli To Nimki, 7 Regional Savoury Snacks That Bring Traditional Indian Flavours To Your Table -
Filmmaker Sanjay Gupta Passes Away At 57: ‘Aatish’ To ‘Kaabil’, Look At His Three-Decade Bollywood Journey -
Halloween 2026: From Chudail To Yakshi, 5 Mysterious Supernatural Beings That Haunt Indian Folklore -
Rashtriya Ekta Diwas 2026: Significance, History And Sardar Vallabhbhai Patel's Role In Uniting India -
Survey Finds 68% Of Previously Married Singles Hesitate To Match With Never-Married Partners -
Diwali 2026: Complete Five-Day Festival Calendar, Dates, Significance And Celebrations -
Weight, Alcohol, Hormones: Pathologist Shares Insights On What Really Shapes A Woman’s Breast Cancer Risk -
Diwali 2026: 5 Healthy Homemade Indian Sweets That Go Beyond Traditional Mithai -
Stroke In Young Women: Neurologist Explains Warning Signs And Hormonal Risk Factors -
‘Star Trek’ And ‘X-Men’ Actor Patrick Stewart Passes Away At 86 After Dementia Battle
Nasal Spray To Beat Hay Fever Expected

Besides hay fever, the treatment will stop the symptoms of asthma from developing without any serious side effects.'A lot of people out there with asthma are not happy with the current therapy. This could be very big deal both medically and financially,' the Daily Express quoted Clive Page, professor of pharmacology at King"s College London, as saying.'The current inhalers can have debilitating side-effects. We hope the new drug can give people the similar kind of treatment but without the side-effects. This is a better way of treating the underlying effects of the diseases and we are cautiously optimistic,' Page added.
Human trial of the drug that stops the allergic reactions will begin within weeks, with the results available early next year. If the tests are successful, allergy charities hope the treatment, to be administered with an inhaler, will dramatically help sufferers of the often-debilitating respiratory condition. The compound, RPL554, is the invention of Sir David Jack, the former research director of Glaxo SmithKline, who developed some of the main respiratory drugs in use today, including the asthma treatment Ventolin. This invention is being hailed as a big step forward in the treatment of asthma and hay fever because it does not involve steroids or other compounds that can have side effects.
About 15-20% of the population of the United States has some degree of hay fever. It is found equally in both men and women. Usually hay fever is seasonal, but it can last all year long if the allergen stays throughout the year. Spring and fall are the main hay fever seasons, with the new treatments fast on their way, we can hope for a reduction in the current figure.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
